Stock Information
Iovance Biotherapeutics Inc (IOVA)
Ticker Symbol: IOVA
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $1,361.60 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -1.1207
Revenue (TTM): $0.65 M
Dividend Yield: N/A%
ROE: -54.54%
Latest News
-
Iovance Therapeutics: Q1 Earnings Miss May Have Created A Buying Opportunity
Fri, May 8, 2026 10:58 AM
-
Chardan Capital Maintains Buy on Iovance Biotherapeutics, Lowers Price Target to $14
Thu, May 7, 2026 8:12 PM
-
Iovance Biotherapeutics, Inc. (IOVA) Q1 2026 Earnings Call Transcript
Thu, May 7, 2026 5:21 PM
-
Transcript : Iovance Biotherapeutics, Inc., Q1 2026 Earnings Call, May 07, 2026
Thu, May 7, 2026 5:05 PM
-
Iovance Biotherapeutics (NASDAQ:IOVA) Reports Q1 Revenue Beat and Raised Guidance, Yet Stock Slips Pre-Market
Thu, May 7, 2026 12:25 PM
-
Iovance Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
Thu, May 7, 2026 12:20 PM
-
Iovance Biotherapeutics: Q1 Earnings Snapshot
Thu, May 7, 2026 7:13 AM
-
Iovance Biotherapeutics Sees FY2026 Sales $350.000M-$370.000M vs $370.477M Est
Thu, May 7, 2026 7:11 AM
-
Iovance Biotherapeutics Q1 EPS $(0.19) Misses $(0.16) Estimate, Sales $71.430M Miss $78.396M Estimate
Thu, May 7, 2026 7:06 AM
-
Iovance Biotherapeutics Highlights Positive First Quarter 2026 Results, Business Achievements and Corporate Updates
Thu, May 7, 2026 7:05 AM
Key Financials
Financial data not available
